The theoretical framework, rationalization, and therapeutic benefits of the MTAs, and the critical issues under the pharmacokinetics, toxicity, and clinical development are discussed, and the future outlook is on AI-based precision antiviral therapeutics.
Vrinda Gupta, Sahil Sharma, Vikrant Abbot et al.· Frontiers in Virology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.